Category Archives: Stem Cell Research

Keri Kimler, vice chair of Texans for Stem Cell Research, talks to CIRM about what information from the World Stem Cell Summit she's excited about sharing with colleagues in Texas. She also discusses a recent symposium she held in Texas to educate people about stem cell research.

Go here to read the rest:
Kerri Kimler: What I'll be telling people back in Texas about the World Stem Cell Summit

A federal judge has issued a temporary halt on the US funding of stem cell research, citing legal restrictions on the destruction of human embryos. Wyatt Andrews reports.

Read more here:
Stem Cell Research Funding Halt

Amazing Discovery - A new stem cell spray gun to heal burn victims.

View original post here:
The Skin Gun stem cell research

Roman Reed spoke with CIRM at the World Stem Cell Summit about what he thinks patients advocates should know about stem cell research. He came to the meeting in Pasadena to talk about stem cell advocacy.

Original post:
Roman Reed: What all patient advocates at the World Stem Cell Summit should know

(Part 4 of 4) Tony Ferrandino spoke at the "Spotlight on Batten Disease," an educational event presented at the CIRM Governing Board Meeting on August 13, 2008. Ferrandino's son, Drew, was diagnosed with Batten disease in January 2007. Ferrandino spoke about his family's journey to identify Drew's condition and to seek out a treatment.

Read the original post:
Batten Disease: Spotlight on Stem Cell Research - A Father's Story

http://WWW.EUX.TV -- Many commentators say that the lack of common rules are obstructing research, denying patients access to the most advanced treatment.

Read the original here:
The EU and stem cell research

thesciencenetwork.org Mark Collins is President of the Glenn Foundation for Medical Research. The purpose of the foundation, founded in 1965 by Paul F. Glenn, is to extend the healthy productive years of life through research on the mechanisms of biological aging.

Continue reading here:
Stemcell Research and Aging - Panel 1

(Part 2 of 3) Arnold Kriegstein, MD, Ph.D., spoke at the "Spotlight on Parkinson's Disease," an educational event presented at the CIRM Governing Board meeting on May 7, 2008. Kriegstein reviewed the limitations of previous Parkinson's clinical trials and discussed the prospects for stem cell-based cell replacement therapies for Parkinson's disease. Kriegstein is a professor of neurology at the University of California, San Francisco School of Medicine.

Excerpt from:
Parkinson's Disease: Spotlight on Stem Cell Research - Arnold Kriegstein

Huntington's disease is an inherited neurodegenerative disorder that typically strikes in a person's thirties and leads to death about 10 to 15 years later. No effective therapy exists for the disease.

Read this article:
Stem Cell Research: Huntington's Disease

(Part 1 of 3) Jeff Bronstein, MD, Ph.D., spoke at the "Spotlight on Parkinson's Disease," an educational event presented at the CIRM Governing Board meeting on May 7, 2008.

See more here:
Parkinson's Disease: Spotlight on Stem Cell Research - Jeff Bronstein